iHuman Q2FY26 Results: Adj. EPS $(0.05), sales down 8.6% YoY

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Adjusted loss per share widened to $(0.05) from $0.08 profit YoY
  • Total revenue declined 8.55% YoY to $25.553 million
  • Net loss of RMB17.5 million contrasts with RMB30.7 million net income last year
  • Average MAUs dropped 13.6% YoY to 20.72 million
  • Cash position decreased to RMB1,007.4 million due to acquisitions and dividends
powered bylight_fuzz_icon
52222095

*this image is generated using AI for illustrative purposes only.

iHuman Inc. (NYSE: IH) reported an adjusted loss per share of $(0.05) for the second quarter ended June 30, 2026, marking a 162.5% decline from earnings of $0.08 in the same period last year. The company recorded net losses of RMB17.5 million (US$2.6 million), reversing from a net income of RMB30.7 million in Q2FY25.

Total revenues stood at $25.553 million, representing an 8.55% decrease from $27.942 million in Q2FY25. In local currency, total revenues fell to RMB173.4 million from RMB210.9 million. The company attributed the swing to profitability to a decline in revenues and increased strategic investments in product development and international expansion.

Financial Performance Overview

The drop in top-line performance was driven by a contraction in the user base and conservative consumer spending in China. Average total monthly active users (MAUs) decreased to 20.72 million, compared with 23.97 million in the year-ago quarter.

Operating expenses rose despite the revenue decline, contributing to an operating loss of RMB20.8 million (US$3.1 million), against an operating income of RMB18.3 million in Q2FY25. Sales and marketing expenses increased 17.2% YoY to RMB52.3 million as the company invested in brand enhancement and promotional activities.

Metric Q2FY26 Q2FY25 Change
Revenue (USD mn) 25.553 27.942 -8.55%
Revenue (RMB mn) 173.4 210.9 -17.8%
Gross Profit (RMB mn) 111.2 140.6 -20.9%
Operating Income (Loss) (RMB mn) (20.8) 18.3 N/A
Net Income (Loss) (RMB mn) (17.5) 30.7 N/A
Adj. EPS (USD) (0.05) 0.08 -162.5%
Avg. MAUs (mn) 20.72 23.97 -13.6%

Strategic Initiatives and Product Updates

CEO Peng Dai highlighted efforts to strengthen the product ecosystem through original IP and global partnerships. Domestically, the Liamiao English-learning IP gained traction, surpassing 300,000 followers on Xiaohongshu. Internationally, the Aha World platform integrated the Gabby’s Dollhouse franchise through a collaboration with Universal Products & Experiences.

Co-CEO Teng Li noted progress from recent acquisitions, including the launch of AI Tianti by All Knowledge and enhanced AI capabilities at Perfect Lingo. CFO Vivien Weiwei Wang stated that investments in AI innovation and international expansion weighed on near-term financial performance but are intended to build long-term resilience.

Balance Sheet and Cash Position

Cash, cash equivalents, and short-term investments stood at RMB1,007.4 million (US$148.5 million) as of June 30, 2026, down from RMB1,154.2 million at December 31, 2025. The decrease was primarily due to payments for annual bonuses, cash dividends, and acquisition considerations for All Knowledge and Perfect Lingo.

Deferred revenue and customer advances were RMB231.5 million, reflecting a slight decline from RMB245.1 million at the end of 2025.

What the Numbers Show

A divergence between revenue contraction and expense growth highlights margin pressure. While revenue fell 17.8% YoY in RMB terms, total operating expenses increased 7.9% to RMB132.0 million. This inverse relationship resulted in a significant swing from operating income to loss. Additionally, gross margin contracted to 64.1% from 66.7% in the prior year, indicating that cost efficiencies did not fully offset the revenue decline.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the continued decline in Monthly Active Users impact iHuman's ability to achieve break-even on its recent international expansion investments?

What specific metrics or timelines has management provided for the integration of the All Knowledge and Perfect Lingo acquisitions to contribute to profitability?

How might the 17.2% increase in sales and marketing expenses affect free cash flow generation given the current revenue contraction?

like19
dislike

iHuman Q1 EPS falls to $0.01, sales drop 8.77%

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

iHuman reported a sharp decline in Q1 earnings, with adjusted EPS falling 85.71% to $0.01 and sales dropping 8.77% to $26.456 million year-over-year.

powered bylight_fuzz_icon
44289845

*this image is generated using AI for illustrative purposes only.

iHuman reported a significant decline in its quarterly financial performance, with adjusted earnings per share falling to $0.01. This represents an 85.71% decrease compared to earnings of $0.07 per share in the same period last year. The company also recorded a drop in revenue, reflecting broader challenges in its operational results during the quarter.

Sales for the period totaled $26.456 million, a decrease of 8.77% from $28.999 million reported in the corresponding quarter of the previous year. The reduction in both earnings and revenue highlights the pressure on the company's profitability and top-line growth.

Financial Performance Summary

The following table outlines the key financial metrics reported by iHuman for the quarter compared to the prior year period:

Metric Current Quarter Year-Ago Quarter Change
Earnings Per Share $0.01 $0.07 -85.71%
Sales $26.456 million $28.999 million -8.77%

The decline in sales directly impacted the bottom line, resulting in the sharp reduction in per-share earnings. The company's ability to reverse this trend will depend on its performance in the coming quarters.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic initiatives does iHuman plan to implement to reverse the decline in revenue and profitability?

How will the company adjust its cost structure to mitigate the impact of reduced sales on earnings?

Are there specific market segments or product lines driving the revenue drop, and what steps are being taken to address them?

like19
dislike